Chordate Medical Holding AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 0.436919 million compared to SEK 0.019538 million a year ago. Revenue was SEK 0.441021 million compared to SEK 0.028394 million a year ago. Net loss was SEK 7.29 million compared to SEK 5.96 million a year ago. Basic loss per share from continuing operations was SEK 0.03 compared to SEK 0.04 a year ago.
For the six months, sales was SEK 0.55734 million compared to SEK 0.08817 million a year ago. Revenue was SEK 0.564589 million compared to SEK 0.111384 million a year ago. Net loss was SEK 14.41 million compared to SEK 13.34 million a year ago.